Neuropharmaceuticals.com
Neurological Pharmaceuticals

Neuropharmaceuticals are pharmacological agents whose primary mode of action is through altering the metabolism of neurotransmitters. Clinical analysis usually applies directly to mechanisms of the diseases of the nervous system which will likely then be translated into disease perception, prevention, and curing, such as studies of brain display techniques, trials to test innovative pharmaceuticals, and formation of novel therapies such as stem cell implants and gene transfer. Some key areas of NINDS clinical investigation include: neurological consequences of AIDS, Alzheimer's sickness, brain tumors, developmental disorders, epilepsy, motor neuron diseases, muscular dystrophies, multiple sclerosis, neurogenetic disorders, pain, Parkinson's malignancy and alternative neurodegenerative disorders, sleep disorders, spinal cord injury, stroke, and traumatic brain injury. (National Institute of Neurological Disorders and Stroke). Neurons consist of three parts. The cell body contains the nucleus, where many of the molecules that the neuron needs to survive and function are manufactured. Dendrites extend out from the cell body like the branches of a tree and receive messages from different nerve cells. Signals then pass from the dendrites through the cell body and may travel away from the cell body down an axon to a different neuron, a muscle cell, or cells in some various organ (National Institute of Neurological Disorders and Stroke). The neuron is usually surrounded by a lot of support cells. Some types of tissue wrap around the axon to form an insulating sheath. This sheath can include a fatty molecule labeled myelin, which rendered insulation for the axon and helps nerve signals navigation faster and farther. Axons might be very short, such as those that carry signals from one cell in the cortex to another cell less than a hair's width away. Or axons could be very long, such as those that carry messages from the brain all the way down the spinal cord (National Institute of Neurological Disorders and Stroke). Rapid advances in genomic science, and their utilization in the genetics sector, are enabling the generation of original biologic agents, tissue and tissues. These advances may help to: prevent and cure illness; function physiological functions; and enhance life. These biotechnological advances have the capacity to supplant biomedical hardware and, in the future, total interior body features by: producing substances required by the body (such as insulin to control diabetes or dopamine to control Parkinson's disease) that are lacking due to illness, genetic abnormality, or injury; performing physiological or structural functions (such as filtration as an artificial kidney, oxygen exchange as a simulated lung, or connectivity as an engineered tendon) that have been impaired by illness, genetic abnormality, or injury; or providing immunity (such as resistance to cancer or viruses). Click on images for info concerning T-shirts about biotech and neurotech: Questions and suggestions concerning the site Neuropharmaceuticals.com may be sent to: Neuropharmaceuticals.com © 2006 by Neuropharmaceuticals.com